Patrizia Viola
Overview
Explore the profile of Patrizia Viola including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
28
Citations
872
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Smith D, Meghji J, Moonim M, Ross C, Viola P, Wickremasinghe M, et al.
Respirol Case Rep
. 2023 Oct;
11(11):e01231.
PMID: 37840600
Here we describe three cases of sarcoidosis which were diagnosed following COVID infection. Treating clinicians should consider post-COVID-19 sarcoidosis in their differential, as it represents a potentially treatable cause of...
2.
Taniere P, Nicholson A, Gosney J, Montero Fernandez M, Bury D, Moore D, et al.
J Clin Pathol
. 2023 May;
77(7):486-494.
PMID: 37258251
Aims: Cancer diagnostics have been evolving rapidly. In England, the new National Health Service Genomic Medicine Service (GMS) provides centralised access to genomic testing via seven regional Genomic Laboratory Hubs....
3.
Chen M, Copley S, Viola P, Lu H, Aboagye E
Semin Cancer Biol
. 2023 May;
93:97-113.
PMID: 37211292
Lung cancer is the leading cause of cancer-related deaths worldwide. It exhibits, at the mesoscopic scale, phenotypic characteristics that are generally indiscernible to the human eye but can be captured...
4.
Kamenova A, Sathyamoorthy T, Bain G, Viola P, Margaritopoulos G
Breathe (Sheff)
. 2023 Mar;
18(4):220218.
PMID: 36865940
https://bit.ly/3Usxcj7.
5.
Chen M, Lu H, Copley S, Han Y, Logan A, Viola P, et al.
J Thorac Oncol
. 2023 Feb;
18(6):718-730.
PMID: 36773776
Introduction: Patient selection for checkpoint inhibitor immunotherapy is currently guided by programmed death-ligand 1 (PD-L1) expression obtained from immunohistochemical staining of tumor tissue samples. This approach is susceptible to limitations...
6.
Rakaee M, Adib E, Ricciuti B, Sholl L, Shi W, Alessi J, et al.
JAMA Oncol
. 2022 Nov;
9(1):51-60.
PMID: 36394839
Importance: Currently, predictive biomarkers for response to immune checkpoint inhibitor (ICI) therapy in lung cancer are limited. Identifying such biomarkers would be useful to refine patient selection and guide precision...
7.
Arora I, Gupta N, Angeles Montero M, Viola P
Pathologica
. 2022 Oct;
114(5):391-394.
PMID: 36305027
Pulmonary mixed squamous and glandular papillomas (MSCGPs) are rare, benign neoplasms with peculiar clinical and histological features. However, on occasion, they can present certain characteristics that overlap with other neoplasms...
8.
Jensen M, Lim E, Dixon L, Quilichini B, Jenkins H, Viola P, et al.
Cytopathology
. 2022 Jul;
33(6):738-741.
PMID: 35867809
This case report describes the cytological features of a rare tumour: diffuse leptomeningeal glioneuronal tumour. This case highlights the value of cerebrospinal fluid analysis when this type of tumour is...
9.
Spinelli M, Du Parcq P, Gupta N, Khorashad J, Viola P
Pathologica
. 2022 Jul;
114(3):221-227.
PMID: 35775708
Background: KRAS mutations are present in up to 30% of patients with lung adenocarcinoma. The two most common KRAS mutations in non-small cell lung cancer (NSCLC) are G12C (~40%) and...
10.
Vigliar E, Pisapia P, Dello Iacovo F, Alcaraz-Mateos E, Ali G, Ali S, et al.
Cancer Cytopathol
. 2022 Jan;
130(5):344-351.
PMID: 35006650
Background: In a previous worldwide survey, the authors showed a drastic reduction in the number of cytological specimens processed during the coronavirus disease 2019 "lockdown" period along with an increase...